The revolutionary PROX™ Antiviral Technology supported by HeiQ Viroblock, a Swiss textile innovator is proven to exhibit significant viral activity against SARS-CoV-2 for >99.99% effectiveness.
Further to in-house innovation and application on self-developed fabrications, we have developed the very first PROX™ Antiviral Fabric in Asia Pacific which is tested effective against >99% SARS-CoV-2 (Covid-19) and Delta variant even after 60 washes based on the latest testing conducted – LS21-02881 at Microbe Investigations AG (MIS) in Switzerland dated January 18, 2022.
The silver technology attracts the oppositely charged viruses and binds permanently to their sulfur groups (immobilized) and then eliminate them following a short exposure of silver on the isolated viruses.
The vesicle technology (Liposomes) helps to deplete the viral membrane of its cholesterol content in minutes, therefore the silver can destroy the virus rapidly.
Textiles provide an ideal surface for harbouring bacteria and viruses.
Over time, bacteria and viruses can be retransmitted from the textile via contact with other surfaces.
Textile treated with HeiQ Viroblock effectively inhibit bacteria & viruses upon contact.
HeiQ Viroblock treated textiles are more resistant to bacteria and viruses.
Viruses and bacteria are scatter around in the air and may spread onto item surfaces. There is risk of transmissions to human body during our daily activities whereas we might touch and bring them around and even bring back to home and our loved ones.
|TEST REPORT NO.||DATE||TEST||STANDARD||RESULT|
|LS22-00673||28/2/2022||Antiviral Activity – SARS-CoV-2 (Omicron)|
after 60 washes
|LS021-02881||3/1/2020||Antiviral Activity – SARS-CoV-2 (Delta)|
afer 60 washes
US CPSC 16 CFR Part 1610-2008
|SINH20800466-3||7/7/2020||BFE after 60 washing||ASTM F2101-19||80.13||👁️|